October 2026 Br J Cardiol 2026;33(4) doi:10.5837/bjc.2026.052 Online First
Mazhar Warraich, Ahmed Haggag, Dawar Ayyaz, Nadia Sunni
Introduction Cardiac pacing devices play a crucial role in the management of bradyarrhythmias and other cardiac conditions by providing electrical stimulation to maintain adequate heart rate and rhythm. These devices have significantly improved patient outcomes and quality of life.1,2 However, despite their effectiveness, there is considerable variability in mortality rates among patients with cardiac pacing devices. Understanding the factors that contribute to mortality in this population is of paramount importance for optimising patient care and outcomes. With an increasingly ageing population, cardiologists are confronted with multi-morbid
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits